Literature DB >> 12080476

Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.

Mehmet Gunduz1, Mamoru Ouchida, Kunihiro Fukushima, Sachio Ito, Yoshimi Jitsumori, Tomoko Nakashima, Noriyuki Nagai, Kazunori Nishizaki, Kenji Shimizu.   

Abstract

Loss of heterozygosity (LOH) has been frequently detected at chromosome 7q31 region in human head and neck squamous cell carcinomas (HNSCC) and many other cancers, suggesting the existence of tumor suppressor genes (TSG). We analysed LOH at 7q31 region in 49 HNSCC by using six polymorphic microsatellite markers and found allelic deletion in 48% (22/46) of the informative cases. We detected two preferentially deleted regions, one is around D7S643 and the other around D7S486. When we redefined the map of 7q31 region according to the contiguous sequences, a recently identified gene, ING3, was found in the proximity of D7S643. ING3 protein harbors the PHD domain highly homologous among ING family proteins, in which we previously found mutations in a related gene, ING1. As only one missense mutation of the ING3 gene was found in HNSCC, we examined the expression level. Reverse-transcription-PCR analysis demonstrated decreased or no expression of ING3 mRNA in 50% of primary tumors as compared with that of matched normal samples. Especially, about 63% of tongue and larynx tumors showed the decrease and a tendency of higher mortality was observed in cases with decreased ING3 expression. All these findings suggest a possibility that the ING3 gene functions as a TSG in a subset of HNSCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080476     DOI: 10.1038/sj.onc.1205540

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  Dickkopf (Dkk)-3 and β-catenin expressions increased in the transition from normal oral mucosal to oral squamous cell carcinoma.

Authors:  Masae Fujii; Naoki Katase; Mathieu Lefeuvre; Mehmet Gunduz; Rosario Rivera Buery; Ryo Tamamura; Hidetsugu Tsujigiwa; Hitoshi Nagatsuka
Journal:  J Mol Histol       Date:  2011-09-20       Impact factor: 2.611

Review 2.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

3.  Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.

Authors:  Silvia S Borkosky; Mehmet Gunduz; Hitoshi Nagatsuka; Levent Bekir Beder; Esra Gunduz; Mahmoud A L Sheikh Ali; Andrea P Rodriguez; Mehmet Zeynel Cilek; Susumu Tominaga; Noboru Yamanaka; Kenji Shimizu; Noriyuki Nagai
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-08       Impact factor: 4.553

4.  Molecular cloning and expression analysis of inhibitor of growth protein 3 (ING3) in the Manila clam, Ruditapes philippinarum.

Authors:  Guang-Wei Hu; Xi-Wu Yan; Yan-Jie Qin; Hong-Tao Nie
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

Review 5.  The MOZ histone acetyltransferase in epigenetic signaling and disease.

Authors:  Samuel Carlson; Karen C Glass
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

6.  Identification of a new target region on the long arm of chromosome 7 in gastric carcinoma by loss of heterozygosity.

Authors:  De-Sheng Weng; Jin-Tian Li; Shi-Juan Mai; Zhi-Zhong Pan; Bing-Jian Feng; Qi-Sheng Feng; Li-Xi Huang; Qi-Jing Wang; Yong-Qiang Li; Xing-Juan Yu; Shi-Ping Chen; Jia He; Jian-Chuan Xia
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

7.  Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chakrapani Chatla; Sanjay Kumar; Selvarangan Ponnazhagan; Tom Callens; Ludwine Messiaen; William E Grizzle; Upender Manne
Journal:  Front Biosci       Date:  2008-01-01

Review 8.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

Review 9.  Structural insight into histone recognition by the ING PHD fingers.

Authors:  Karen S Champagne; Tatiana G Kutateladze
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

10.  MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.

Authors:  George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Demosthenis Skarlos
Journal:  J Oncol       Date:  2009-12-29       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.